Human adipose stem cell differentiation is highly affected by cancer cells both in vitro and in vivo: Implication for autologous fat grafting

Cell Death and Disease

Volumn 8, Issue 1, 2017, Pages

  Paino, Francesca ^a   La Noce, Marcella ^a   Di Nucci, Diego ^a   Nicoletti, Giovanni Francesco ^a   Salzillo, Rosa ^a   De Rosa, Alfredo ^a   Ferraro, Giuseppe Andrea ^a   Papaccio, Gianpaolo ^a   Desiderio, Vincenzo ^a   Tirino, Virginia ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BETA1 INTEGRIN; CD31 ANTIGEN; CD324 ANTIGEN; LEPTIN; LYMPHOCYTE ANTIGEN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; VASCULOTROPIN; VIMENTIN;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL CELL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MCF-7 CELL LINE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; MCF-7 CELLS; MESENCHYMAL STROMAL CELLS; MICE; NEOVASCULARIZATION, PATHOLOGIC;

EID: 85013377921     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.308     Document Type: Article

References (35)

1. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrowderived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002; 62: 3603-3608.
2. Hall B, Andreeff M, Marini F. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 2007; 180: 263-283.
3. Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM et al. Monocyte chemotactic protein 1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res 2007; 13: 5020-5027.
4. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009; 4: e4992.
5. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW et al. Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature 2007; 449: 557-563.
6. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J et al. Human bone marrowderived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65: 3307-3318.
7. Brune JC, Tormin A, Johansson MC, Rissler P, Brosj O, Lefvenberg R et al. Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bonemarrow counterparts. Int J Cancer 2011; 129: 319-330.
8. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-1659.
9. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.
10. Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proc Natl Acad Sci USA 2012; 109: 9786-9791.
11. Liotta LA, Kohn EC. The microenvironment of the tumor host interface. Nature 2001; 411: 375-379.
12. Lazennec G, Richmond A. Chemokines and chemokine receptors: new insights into cancerrelated inflammation. Trends Mol Med 2010; 16: 133-144.
13. Yao C, Lin Y, Chua MS, Ye CS, Bi J, Li W et al. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer 2007; 121: 1949-1957.
14. LeBedis C, Chen K, Fallavollita L, Boutros T, Brodt P. Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 2002; 100: 2-8.
15. De Francesco F, Tirino V, Desiderio V, Ferraro G, D'Andrea F, Giuliano M et al. Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLoS One 2009; 4: e6537.
16. D' Andrea F, De Francesco F, Ferraro GA, Desiderio V, Tirino V, De Rosa A et al. Large-scale production of human adipose tissue from stem cells: a new tool for regenerative medicine and tissue banking. Tissue Eng Part C Methods 2008; 14: 233-242.
17. Ferraro GA, De Francesco F, Nicoletti G, Paino F, Desiderio V, Tirino V et al. Human adipose CD34+ CD90+ stem cells and collagen scaffold constructs grafted in vivo fabricate loose connective and adipose tissues. J Cell Biochem 2013; 114: 1039-1049.
18. Desiderio V, De Francesco F, Schiraldi C, De Rosa A, La Gatta A, Paino F et al. Human Ng2+ adipose stem cells loaded in vivo on a new crosslinked hyaluronic acid-Lys scaffold fabricate a skeletal muscle tissue. J Cell Physiol 2013; 228: 1762-1773.
19. Kozlik M, Wojcicki P. The use of stem cells in plastic and reconstructive surgery. Adv Clin Exp Med 2014; 23: 1011-1017.
20. Longo UG, Rizzello G, Berton A, Ciuffreda M, Migliorini F, Khan WS et al. Potential of adipose derived stem cells in orthopaedic surgery. Curr Stem Cell Res Ther 2013; 8: 418-421.
21. Gimble MJ, Bunnell BA, Guilak F. Human adipose-derived cells: an update on the transition to clinical translation. Regen Med 2012; 7: 225-235.
22. Perrot P, Rousseau J, Bouffaut AL, Radini F, Cassagnau E, Deschaseaux F et al. Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence. PLoS One 2010; 5: e10999.
23. Chaput B, Foucras L, Le Guellec S, Grolleau JL, Garrido I. Recurrence of an invasive ductal breast carcinoma 4 months after autologous fat grafting. Plast Reconstr Surg 2013; 131: 123e-124ee.
24. Mizuno H, Tobita M, Uysal AC. Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 2012; 30: 804-810.
25. Zielins ER, Luan A, Brett EA, Longaker MT, Wan DC. Therapeutic applications of human adipose-derived stromal cells for soft tissue reconstruction. Discov Med 2015; 19: 2452-2453.
26. Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, Donnenberg VS. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011; 17: 93-106.
27. Donnenberg VS, Zimmerlin L, Rubin JP, Donnenberg AD. Regenerative therapy after cancer: what are the risks? Tissue Eng Part B Rev 2010; 16: 567-575.
28. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228.
29. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells 2014; 32: 1380-1389.
30. d'Aquino R, Graziano A, Sampaolesi M, Laino G, Pirozzi G, De Rosa A et al. Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. Cell Death Differ 2007; 14: 1162-1171.
31. San Martin R, Barron DA, Tuxhorn JA, Ressler SJ, Hayward SW, Shen X et al. Recruitment of CD34+ fibroblasts in tumor-associated reactive stroma. The reactive microvasculature hypothesis. Am J Pathol 2014; 184: 1860-1870.
32. Chauhan H, Abraham A, Phillips JRA, Pringle JH, Walker RA, Jones JL. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 2003; 56: 271-276.
33. Diaz-Flores L, Gutiarrez R, Garcia MP, Siez FJ, Diaz-Flores L Jr, Valladares F et al. CD34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymalcells. Location, morphology, function and role in pathology. Histol Histopathol 2014; 29: 831-870.
34. Catteau X, Simon P, Vanhaeverbeek M, Noel JC. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast. PLoS One 2013; 8: e57773.
35. Singh AM, Reynolds D, Cliff T, Ohtsuka S, Mattheyses AL, Sun Y et al. Signaling network cross-talk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 2012; 10: 312-326.